TWD
URGN icon

True Wealth Design’s UroGen Pharma URGN Stock Holding History

True Wealth Design’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589 Hold
16
– – ﹤0.01% 2149
2026
Q1 		$288 Hold
16
– – ﹤0.01% 2237
2025
Q4 		$375 Hold
16
– – ﹤0.01% 2046
2025
Q3 		$320 Hold
16
– – ﹤0.01% 2160
2025
Q2 		$220 Sell
16
-162
-91% -$1.55K ﹤0.01% 2044
2025
Q1 		$1.97K Buy
+178
New +$1.9K ﹤0.01% 1011
2024
Q4 		– Sell
-161
Closed -$2.04K – 1520
2024
Q3 		$2.04K Buy
+161
New +$2.39K ﹤0.01% 777

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

True Wealth Design's URGN Position: Q2 2026 in Review

True Wealth Design held its UroGen Pharma (URGN) position steady in Q2 2026 at 16 shares worth $589. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

True Wealth Design first reported a position in URGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $2.04K in Q3 2024. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • True Wealth Design held 16 shares of UroGen Pharma worth $589 as of Q2 2026.
  • True Wealth Design left its UroGen Pharma share count unchanged in Q2 2026.
  • UroGen Pharma made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2149 holding.
  • True Wealth Design first reported a position in UroGen Pharma in Q3 2024 and has held it in 7 quarters since.
  • True Wealth Design's UroGen Pharma position peaked at $2.04K in Q3 2024.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.